chr4-47406692-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000812.4(GABRB1):​c.846A>G​(p.Thr282Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.297 in 1,613,724 control chromosomes in the GnomAD database, including 74,786 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6283 hom., cov: 32)
Exomes 𝑓: 0.30 ( 68503 hom. )

Consequence

GABRB1
NM_000812.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.03
Variant links:
Genes affected
GABRB1 (HGNC:4081): (gamma-aminobutyric acid type A receptor subunit beta1) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 1 subunit. It is mapped to chromosome 4p12 in a cluster comprised of genes encoding alpha 4, alpha 2 and gamma 1 subunits of the GABA A receptor. Alteration of this gene is implicated in the pathogenetics of schizophrenia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 4-47406692-A-G is Benign according to our data. Variant chr4-47406692-A-G is described in ClinVar as [Benign]. Clinvar id is 1280390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.03 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.315 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GABRB1NM_000812.4 linkc.846A>G p.Thr282Thr synonymous_variant Exon 8 of 9 ENST00000295454.8 NP_000803.2 P18505-1X5DNL6
GABRB1XM_024453976.2 linkc.747A>G p.Thr249Thr synonymous_variant Exon 8 of 9 XP_024309744.1
GABRB1XM_024453977.2 linkc.747A>G p.Thr249Thr synonymous_variant Exon 9 of 10 XP_024309745.1
GABRB1XM_017007985.2 linkc.195A>G p.Thr65Thr synonymous_variant Exon 4 of 5 XP_016863474.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GABRB1ENST00000295454.8 linkc.846A>G p.Thr282Thr synonymous_variant Exon 8 of 9 1 NM_000812.4 ENSP00000295454.3 P18505-1

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42252
AN:
151994
Hom.:
6277
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.268
Gnomad AMI
AF:
0.237
Gnomad AMR
AF:
0.221
Gnomad ASJ
AF:
0.334
Gnomad EAS
AF:
0.0154
Gnomad SAS
AF:
0.203
Gnomad FIN
AF:
0.286
Gnomad MID
AF:
0.369
Gnomad NFE
AF:
0.318
Gnomad OTH
AF:
0.280
GnomAD3 exomes
AF:
0.255
AC:
64042
AN:
251168
Hom.:
9420
AF XY:
0.261
AC XY:
35407
AN XY:
135774
show subpopulations
Gnomad AFR exome
AF:
0.272
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.334
Gnomad EAS exome
AF:
0.00810
Gnomad SAS exome
AF:
0.203
Gnomad FIN exome
AF:
0.273
Gnomad NFE exome
AF:
0.326
Gnomad OTH exome
AF:
0.287
GnomAD4 exome
AF:
0.299
AC:
436528
AN:
1461612
Hom.:
68503
Cov.:
39
AF XY:
0.297
AC XY:
216055
AN XY:
727110
show subpopulations
Gnomad4 AFR exome
AF:
0.276
Gnomad4 AMR exome
AF:
0.162
Gnomad4 ASJ exome
AF:
0.338
Gnomad4 EAS exome
AF:
0.0255
Gnomad4 SAS exome
AF:
0.209
Gnomad4 FIN exome
AF:
0.270
Gnomad4 NFE exome
AF:
0.322
Gnomad4 OTH exome
AF:
0.288
GnomAD4 genome
AF:
0.278
AC:
42284
AN:
152112
Hom.:
6283
Cov.:
32
AF XY:
0.273
AC XY:
20325
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.268
Gnomad4 AMR
AF:
0.220
Gnomad4 ASJ
AF:
0.334
Gnomad4 EAS
AF:
0.0154
Gnomad4 SAS
AF:
0.203
Gnomad4 FIN
AF:
0.286
Gnomad4 NFE
AF:
0.318
Gnomad4 OTH
AF:
0.282
Alfa
AF:
0.308
Hom.:
12494
Bravo
AF:
0.274
Asia WGS
AF:
0.128
AC:
445
AN:
3478
EpiCase
AF:
0.337
EpiControl
AF:
0.338

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 15, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 27. Only high quality variants are reported. -

Developmental and epileptic encephalopathy, 45 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.012
DANN
Benign
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6289; hg19: chr4-47408709; COSMIC: COSV54982086; COSMIC: COSV54982086; API